High Tide - CEO, Raj Grover.
CEO, Raj Grover.
Source: LinkedIn.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • High Tide (HITI) will open its first Canna Cabana retail cannabis store in British Columbia to customers today, Wednesday, July 13
  • The retail store is located at 10027 100 Street in Fort St. John, BC
  • This store is the 128th branded retail location of High Tide in Canada, and its first in British Columbia
  • High Tide is a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets
  • High Tide Inc. opened the day’s trading at $2.68 per share

High Tide (HITI) has announced the opening of its Canna Cabana retail cannabis store in British Columbia.

The store located at 10027 100 Street in Fort St. John, British Columbia will sell recreational cannabis products and consumption accessories for adult use.

This store is the 128th branded retail location of High Tide in Canada, and its first in British Columbia, selling recreational cannabis products and consumption accessories.

The store is in Fort St. John, British Columbia, close to numerous businesses, and is only minutes from the Alaska Highway, bringing residents and visitors into the city.

“Our first organic store opening in British Columbia is a much-awaited and very positive milestone for High Tide,” said Raj Grover, President and Chief Executive Officer of High Tide.

“With this foothold in British Columbia, I anticipate that we will be able to expand quickly through both organic growth and strategic acquisitions, putting us in a position to reach the cap of 8 stores in the coming months,” he added.

High Tide is a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets.

 High Tide Inc. opened the day’s trading at $2.68 per share.

More From The Market Herald

" Update from Revive Therapeutics (CSE:RVV) on Phase 3 clinical trial for Bucillamine in COVID-19

Revive Therapeutics (RVV) has provided an update on the company’s U.S. Food & Drug Administration (FDA) Phase 3 clinical trial.

" EnWave (TSXV:ENW) signs technology evaluation agreement with Canadian cannabis cultivator

EnWave Corporation (ENW) has signed an agreement with a Canadian cannabis company to use its 10kW Radiant Energy Vacuum (REV) technology.

" Core One Labs (CSE:COOL) subsidiary Vocan successfully converts Psilocin precursor into Psilocybin

Core One Labs (CSE:COOL) subsidiary Vocan Biotechnologies has converted psilocin developed by Awakened Biosciences into viable API psilocybin.